Blue Trust Inc’s Twist Bioscience TWST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-11
Closed -$310 – 2728
2025
Q3
$310 Hold
11
– – ﹤0.01% 2479
2025
Q2
$405 Sell
11
-213
-95% -$7.36K ﹤0.01% 2337
2025
Q1
$8.79K Hold
224
– – ﹤0.01% 1949
2024
Q4
$10.4K Sell
224
-3,586
-94% -$162K ﹤0.01% 1828
2024
Q3
$188K Buy
3,810
+2,635
+224% +$125K ﹤0.01% 886
2024
Q2
$40.3K Buy
1,175
+1,136
+2,913% +$46.3K ﹤0.01% 1342
2024
Q1
$1.34K Sell
39
-211
-84% -$7.62K ﹤0.01% 1890
2023
Q4
$5K Buy
+250
New +$5.78K ﹤0.01% 1868
2023
Q2
– Sell
-7
Closed – – 2528
2023
Q1
$0 Sell
7
-129
-95% -$2.85K ﹤0.01% 2642
2022
Q4
$4K Buy
136
+54
+66% +$1.57K ﹤0.01% 1818
2022
Q3
$2K Buy
+82
New +$3.48K ﹤0.01% 1838

Other funds holding TWST

Blue Trust Inc's TWST Position: Q4 2025 in Review

Blue Trust Inc sold out of Twist Bioscience (TWST) in Q4 2025, closing a stake of 11 shares — an estimated $310 sold.

Blue Trust Inc first reported a position in TWST in Q3 2022 and held it in 11 quarters. The position peaked at $188K in Q3 2024. 244 funds tracked by Wall St. Rank hold TWST as of Q4 2025.

  • Blue Trust Inc reported no remaining Twist Bioscience position as of Q4 2025 after selling out during the quarter.
  • Blue Trust Inc sold 11 Twist Bioscience shares in Q4 2025, an estimated $310.
  • Blue Trust Inc first reported a position in Twist Bioscience in Q3 2022 and held it in 11 quarters.
  • Blue Trust Inc's Twist Bioscience position peaked at $188K in Q3 2024.
  • 244 funds tracked by Wall St. Rank held Twist Bioscience as of Q4 2025.

Based on Blue Trust Inc's 13F filing for Q4 2025, filed 16 Jan 2026.